Clinical Trial

Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)

Recruiting
View on ClinicalTrials.gov →
Summary
CT imaging data and MR imaging data from liver cancer (hepatocellular carcinoma) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-01.
Trial Details
NCT Number NCT07059936
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Hepatocellular Carcinoma (HCC)
Enrollment 350 participants
Start Date 2025-07
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-07-22